We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection (TITAN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04447235
Recruitment Status : Terminated (futility analysis has demonstrated no difference between arms)
First Posted : June 25, 2020
Last Update Posted : August 9, 2022
Sponsor:
Information provided by (Responsible Party):
Instituto do Cancer do Estado de São Paulo

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : June 30, 2022
Actual Study Completion Date : June 30, 2022